The term “childhood Alzheimer’s” suggests that it is a form of Alzheimer’s disease that specifically occurs in children. It turns out, this is a…
Since the early days of the novel coronavirus pandemic, researchers found that people living with Alzheimer’s were at a higher risk of severe COVID-19…
Analyzing large databases of human data, scientists identified a “water pill” called bumetanide, which reduced the risk of developing Alzheimer’s for people with a…
Scientists are looking toward microglia cells as therapeutic targets for Alzheimer’s. Microglia, known as the janitors of our brains, are responsible for clearing harmful…
This article is part of the series Diversity & Dementia, an editorially independent series produced by Being Patient with support provided by Eisai. One day, young Andres…
A new approach to genome sequencing newly identifies 13 rare gene variants potentially associated with Alzheimer’s. Dr. Rudy Tanzi, vice chair of neurology and…
Amid growing evidence of the neurological complications of COVID-19, which range from loss of sense of taste and smell, to ‘brain fog,’ to stroke…
There are a lot of unanswered questions about Alzheimer’s, but one thing the Alzheimer’s community knows well is that getting older is the disease’s…
Being Patient editors round up a selection of our top reader submissions and Patient Perspectives of 2020. Stories from the Being Patient Community Eugenia…
Scientists are barreling toward a future in which, thanks to CRISPR, it is possible to edit the genetic make-up of brain cells to prevent…
Alzheimer’s disease is more prevalent among Black Americans than among white Americans. By some estimates, it is 14% more common among Black Americans; by others, their…
While researchers have known that the ApoE4 genetic variant is the strongest genetic risk factor for Alzheimer’s and related dementias, this finding is largely…
Researchers in Germany studied the effects of ApoE4, the best known genetic factor for Alzheimer’s Disease, on the brains of 82 young adults —…
Alzheimer’s main hallmarks — beta-amyloid plaques and tau tangles — have long been the focus of the quest to come up with an Alzheimer’s…
Protein plaques and tangles have long been thought to be the cause of Alzheimer’s disease. Now, scientists are looking beyond those biomarkers at a…